Chen, M., Wang, M., Xu, S., Guo, X., & Jiang, J. (2015). Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathway. Oncotarget.

Chen, Meiyuan, Min Wang, Simiao Xu, Xingjun Guo, and Jianxin Jiang. "Upregulation of MiR-181c Contributes to Chemoresistance in Pancreatic Cancer By Inactivating the Hippo Signaling Pathway." Oncotarget 2015.

Chen, Meiyuan, et al. "Upregulation of MiR-181c Contributes to Chemoresistance in Pancreatic Cancer By Inactivating the Hippo Signaling Pathway." Oncotarget 2015.